Newtyn Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-200,000
Closed -$5.02M – 36
2025
Q1
$5.02M Sell
200,000
-70,000
-26% -$1.77M 0.79% 24
2024
Q4
$7.42M Sell
270,000
-230,000
-46% -$6.41M 1.29% 23
2024
Q3
$14.4M Hold
500,000
– – 2.21% 16
2024
Q2
$12.4M Buy
500,000
+134,000
+37% +$3.8M 2.33% 15
2024
Q1
$11.8M Buy
366,000
+147,913
+68% +$5.5M 2.35% 15
2023
Q4
$8.87M Sell
218,087
-56,913
-21% -$2.09M 1.74% 19
2023
Q3
$9.5M Buy
275,000
+5,000
+2% +$195K 2.34% 14
2023
Q2
$11M Buy
270,000
+1,718
+0.6% +$70.1K 2.59% 14
2023
Q1
$10.4M Buy
268,282
+13,282
+5% +$546K 2.04% 18
2022
Q4
$11.3M Buy
255,000
+75,000
+42% +$3.16M 2.34% 16
2022
Q3
$7.68M Buy
180,000
+10,000
+6% +$512K 1.69% 21
2022
Q2
$9.49M Buy
170,000
+56,600
+50% +$3.36M 1.8% 20
2022
Q1
$7.03M Buy
+113,400
New +$6.94M 1.68% 23

Other funds holding LKFT

Newtyn Management's LKFT Position: Q2 2025 in Review

Newtyn Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2025, closing a stake of 200,000 shares — an estimated $5.02M sold.

Newtyn Management first reported a position in LKFT in Q1 2022 and held it in 13 quarters. The position peaked at $14.4M in Q3 2024. 85 funds tracked by Wall St. Rank hold LKFT as of Q2 2025.

  • Newtyn Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2025 after selling out during the quarter.
  • Newtyn Management sold 200,000 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2025, an estimated $5.02M.
  • Newtyn Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2022 and held it in 13 quarters.
  • Newtyn Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $14.4M in Q3 2024.
  • 85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2025.

Based on Newtyn Management's 13F filing for Q2 2025, filed 14 Aug 2025.